Perioperative clinical and economic outcomes associated with replacing first-generation high molecular weight hydroxyethyl starch (Hextend®) with low molecular weight hydroxyethyl starch (Voluven®) at a large medical center

BACKGROUND: Several plasma volume expander alternatives exist to enhance intravascular volume status in patients undergoing surgery. The optimal intravascular volume expander in the perioperative setting is currently unknown. Low molecular weight hetastarch, Voluven® (130/0.4), may have a better saf...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Perioper Med (Lond)
Main Authors: Bartz, Raquel R, White, William D, Gan, Tong J
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2015
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4349603/
https://ncbi.nlm.nih.gov/pubmed/25741439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13741-015-0013-0
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki